Odonate Therapeutics, Inc. Restructuring Costs
Odonate Therapeutics, Inc. reported Restructuring Costs of -$10.00 thousand for the 3-month period ending 2021-09-30, per its 10-Q filed 2021-11-10.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2021-11-10
- Odonate Therapeutics, Inc. restructuring costs for the quarter ending 2021-09-30 was -$10.00K.
- Odonate Therapeutics, Inc. restructuring costs for the quarter ending 2021-06-30 was $6.17M.
- Odonate Therapeutics, Inc. restructuring costs for the quarter ending 2021-03-31 was $5.48M.
| Period end | Restructuring Costs 3 month | Restructuring Costs 6 month | Restructuring Costs 9 month |
|---|---|---|---|
| 2021-09-30 | -$10.00K 10-Q · filed 2021-11-10 | $6.16M derived: sum of 2 quarters · filed 2021-11-10 | $11.64M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $6.17M 10-Q · filed 2021-07-27 | $11.65M 10-Q · filed 2021-07-27 | |
| 2021-03-31 | $5.48M 10-Q · filed 2021-05-14 |